Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.69 USD | -1.25% | +17.39% | -11.32% |
14/05 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 23Cr | |
+34.54% | 47TCr | |
+27.57% | 27TCr | |
+6.66% | 14TCr | |
+32.61% | 9.61TCr | |
+6.99% | 9.25TCr | |
+61.15% | 6.01TCr | |
+18.75% | 4.8TCr | |
+24.94% | 3.79TCr | |
+0.13% | 3.57TCr |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- B. Riley Lowers OptimizeRx's Price Target to $56 from $71, Says Consensus Estimates at Risk of Moving Lower into Q2 Print; Keeps Buy Rating